Evidence map›Paper›PMID 42631116›Full record

ArticleCase reports in ophthalmological medicine2026

Maculopathy Linked to Light Chain Monoclonal Gammopathy: A Case Report.

Christina Mitsi, Doukas Dardabounis, Lydia Inglezou, Konstantinos Liapis, Georgios Labiris, Tryfon Rotsos

Abstract read
In one paragraph

Article in Case reports in ophthalmological medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Maculopathy Linked to Light Chain Monoclonal Gammopathy: A Case Report.Case reports in ophthalmological medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christina MitsiDepartment of Ophthalmology, University Hospital of Alexandroupolis, Alexandroupolis, Greece, pgna.gr.ORCID https://orcid.org/0000-0003-2141-5726
Doukas DardabounisDepartment of Ophthalmology, University Hospital of Alexandroupolis, Alexandroupolis, Greece, pgna.gr.ORCID https://orcid.org/0000-0001-7105-9577
Lydia InglezouDepartment of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece, duth.gr.ORCID https://orcid.org/0000-0002-5302-4511
Konstantinos LiapisDepartment of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece, duth.gr.ORCID https://orcid.org/0000-0003-1165-9639
Georgios LabirisDepartment of Ophthalmology, University Hospital of Alexandroupolis, Alexandroupolis, Greece, pgna.gr.ORCID https://orcid.org/0000-0003-4364-1943
Tryfon RotsosDepartment of Ophthalmology, University Hospital of Alexandroupolis, Alexandroupolis, Greece, pgna.gr.ORCID https://orcid.org/0000-0001-7152-4571

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monoclonal gammopathies can produce a spectrum of ocular manifestations, most commonly paraproteinemic keratopathy, but retinal involvement, though rare, may be vision-threatening. We report a case of paraproteinemic maculopathy in a 49-year-old female with a history of hypertension and albuminuria, who presented with blurred vision and renal impairment. Examination revealed subretinal yellow infiltrates in the posterior pole with hyperautofluorescence on fundus autofluorescence and subretinal fluid with hyperreflective deposits above the retinal pigment epithelium on optical coherence tomography. Laboratory workup identified an excess of free kappa light chains in serum. A diagnosis of light chain deposition disease (LCDD) was made on the basis of a renal biopsy, and systemic therapy was initiated. At 5 months posttreatment, best-corrected visual acuity improved to 20/20 OU, with resolution of subretinal fluid, although sub-RPE deposits persisted. This case illustrates that monoclonal free light chains can induce maculopathy through RPE and choroidal depositions, mimicking other macular diseases. Early recognition and systemic treatment targeting the underlying plasma cell disorder are essential for visual recovery. Ophthalmologists should maintain a high index of suspicion for paraproteinemic maculopathy in patients with atypical serous macular detachments, particularly when the findings are bilateral or associated with subtle systemic signs, emphasizing the need for a multidisciplinary approach.

Identifiers

PMID42631116
PMCPMC13495553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.